Our study found that the second-order interaction of dose30_g-SLC47A2 rs12943590 might have a significant effect on FINS in patients with type 2 diabetes taking metformin; however, other interaction models were not statistically significant (p > 0.05). Here, SLC47A2 is linked to type 2 diabetes mellitus.